Effectiveness and safety of endoscopic ultrasound-guided radiofrequency ablation for pancreatic metastases of renal cell carcinoma.

Fiche publication

Date publication

mai 2025

Journal

Endoscopy international open

Auteurs

Membres identifiés du Cancéropôle Est :
Dr VUITTON Lucine

Tous les auteurs :
Stouvenot M, Koch S, Frontzcak A, D'Engremont C, Boinette A, Doussot A, Maurina T, Vuitton L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40376026

Résumé

Pancreatic metastases from renal cell carcinoma (RCC) are usually managed surgically but with significant morbidity. As an alternative, endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has shown promising results in treatment of pancreatic neuroendocrine tumors. The aim of our study was to assess technical success, effectiveness, and safety of EUS-RFA in patients with pancreatic metastases of RCC.